Hansa Investment Company Limited

Equities

HAN

BMG428941162

Investment Management & Fund Operators

Market Closed - London S.E. Other stock markets 11:35:20 2024-05-17 EDT			5-day change	1st Jan Change
219 ^GBX	0.00%		-0.90%	+9.50%

04-25	Hansa Investment Company Limited Expects to Pay Four Interim Dividends for Its Financial Year Ending 31 March 2025	CI
04-09	Hansa Investment Company Limited Announces Fourth Interim Dividend for the Financial Year Ended 31 March 2024, Payable on 31 May 2024	CI

Hansa Investment Company Limited Appoints Nadya Wells as Non-Executive Director

September 18, 2019 at 10:50 am

Baring Emerging Europe plc has been informed that Mrs. Nadya Wells, a Non-Executive Director of the company, has been appointed as a non-executive director of Hansa Investment Company Limited with effect from 02 September 2019.

Latest news about Hansa Investment Company Limited

Hansa Investment Company Limited Expects to Pay Four Interim Dividends for Its Financial Year Ending 31 March 2025	04-25	CI
Hansa Investment Company Limited Announces Fourth Interim Dividend for the Financial Year Ended 31 March 2024, Payable on 31 May 2024	04-09	CI
Hansa Investment Company Limited Declares Third Interim Dividend for the Financial Year Ending 31 March 2024, Payable on 23 February 2024	01-09	CI
Hansa Investment Company Limited Reports Earnings Results for the Half Year Ended September 30, 2023	11-16	CI
Hansa Investment Company Limited Declares Second Interim Dividend for the Financial Year Ending 31 March 2024, Payable on November 24, 2023	23-10-10	CI
Hansa Biopharma Announces Encouraging High-Level Results for First-In-Human Trial of HNSA-5487	23-10-09	CI
Hansa Investment Company Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-09-08	CI
Hansa Investment Company Limited Appoints Dr. Hitto Kaufmann as Chief Scientific Officer	23-09-01	CI
Hansa Investment Company Limited Announces First Patient Treated with Imlifidase in an Investigator-Initiated Phase 2 Study in Anca-Associated Vasculitis	23-07-19	CI
Hansa Investment Company Limited Announces First Interim Dividend for the Year Ended 31 March 2024, Payable on August 25, 2023	23-07-11	CI
Hansa Biopharma Announces Positive Reimbursement Decision for Idefirix in Belgium as Desensitization Treatment for Highly Sensitized Patients in Kidney Transplantation	23-06-01	CI
Hansa Investment Company Limited Expects to Pay Four Interim Dividends for its Financial Year Ending 31 March 2024, Payable on August 2023, November 2023, February 2024 and May 2024 Respectively	23-04-11	CI
Hansa Investment Company Limited Announces Its Fourth Interim Distribution for the Company's Financial Year Ended March 31, 2023, Payable on 26 May 2023	23-04-11	CI
Hansa Investment Company Limited Announces Executive Changes	23-02-02	CI
Hansa Investment Company Limited Announces Third Interim Distribution for the Financial Year Ended March 31, 2023, Payable on February 24, 2023	23-01-10	CI
Hansa Investment Company Limited Reports Earnings Results for the Half Year Ended September 30, 2022	22-12-01	CI
Hansa Investment Company Limited Announces Second Interim Distribution for the Financial Year Ended 31 March 2023, Payable on 25 November 2022	22-10-11	CI
Hansa Investment Company Limited Announces First Interim Distribution for the Financial Year Ending March 31, 2023, Payable on August 26, 2022	22-07-12	CI
Hansa Investment Company Limited Elects Peter Nicklinas Chair of the Board of Directors	22-06-30	CI
Hansa Investment Company Limited Reports Earnings Results for the Full Year Ended March 31, 2022	22-06-17	CI
Hansa Investment Company Limited Expects to Pay Four Interim Dividends, Payable in August 2022, November 2022, February 2023 and May 2023	22-04-12	CI
Hansa Investment Company Limited Declares Fourth Interim Distribution for Financial Year Ending 31 March 2022, Payable on 27 May 2022	22-04-12	CI
Hansa Investment Company Limited Declares Third Interim Distribution for Financial Year Ending 31 March 2022, Payable on 28 February 2022	22-01-11	CI
Hansa Investment Company Limited Reports Earnings Results for the Half Year Ended September 30, 2021	21-11-23	CI
Hansa Investment Company Limited Announces Second Interim Distribution for the Financial Year Ended 31 March 2022, Payable 26 November 2021	21-10-07	CI

Chart Hansa Investment Company Limited

Duration

Period

More charts

Company Profile

Hansa Investment Company Limited is an externally managed closed-ended investment company. The Companyâs investment objective is to grow the net assets of the Company over the medium to long-term by investing in a diversified and multi-strategy portfolio. The Company seeks to achieve its investment objective by investing in third-party funds, global equities and other international financial securities. The Company also invests in quoted and unquoted securities. It invests in various sectors, including industrials, financials, information technology, health care, consumer discretionary, materials, communications services, energy and others. Hansa Capital Partners LLP is the investment manager of the Company.

Sector

Investment Management & Fund Operators

Calendar

2024-06-19 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

2.19 GBP

Average target price

2.1 GBP

Spread / Average Target

-4.11%

Consensus

Annual profits - Rate of surprise

Company calendar

Sector Other Investment Management & Fund Operators

	1st Jan change	Capi.
HANSA INVESTMENT COMPANY LIMITED	+9.50%	331M
BLACKROCK, INC.	+0.05%	121B
UBS GROUP AG	+5.52%	97.29B
BROOKFIELD CORPORATION	+13.89%	68.9B
APOLLO GLOBAL MANAGEMENT, INC.	+20.97%	64.34B
BANK OF NEW YORK MELLON CORPORATION (THE)	+14.31%	44.5B
AMERIPRISE FINANCIAL, INC.	+14.29%	43.12B
3I GROUP PLC	+22.18%	36.25B
T. ROWE PRICE GROUP INC.	+8.42%	26.07B
STATE STREET CORPORATION	+0.71%	23.5B

Other Investment Management & Fund Operators